Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,520.00    -16.00 (-1.04%)
Bid:
1,510.00
Ask:
1,522.00
Spread: 12.00 (0.795%)
Market Cap: £790.79m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Director retirement

14 Mar 2023 07:00

RNS Number : 7913S
M. P. Evans Group PLC
14 March 2023
Β 

M.P. EVANS GROUP PLC

("the Group" or "M.P. Evans")

Β 

DIRECTOR RETIREMENT

M.P. Evans Group PLC, a producer of sustainable Indonesian palm oil, announces the following change to its board of directors.

Β 

Philip Fletcher

Β 

The board of directors of M.P. Evans ("the board") announces that Philip Fletcher, a non-executive director, will be retiring from the board on 31 July 2023. Philip has worked for the Group for 41 years, giving loyal and invaluable service to several Group companies, including this company, both as M.P. Evans Group PLC and in its former guise as Rowe Evans Investments PLC, as well as to others such as Bertam Holdings PLC and Lendu Holdings PLC.

Β 

He has held various roles, including finance director, managing director, chairman and, more recently, non-executive director. As an executive director, he was central to the Group's operations and growth. He played a pivotal role in devising the strategy, formed in 2005, to rationalise the former grouping of companies into a single Company, to sell its Malaysian estates and to focus on the expansion of its sustainable palm-oil interests in Indonesia. This has resulted in the hugely enlarged Group we are today. As a non-executive director, he has been independent minded and consistently provided valuable and insightful advice.

Β 

The board wishes to express its gratitude to Philip for his exceptional contribution over his remarkable period of service to the Group.Β 

Β 

Peter Hadsley-Chaplin, chairman, commented "Philip has been at the heart of the Group's operations, its growth and its success for over forty years. Whilst his wisdom and expertise on the board will be much missed, we shall, of course, stay closely in touch with him in the future".

Β 

Β 

14 March 2023

Β 

Enquiries:

Β 

M.P. Evans Group PLC

Telephone: 01892 516333

Peter Hadsley-Chaplin - chairman

Matthew Coulson - chief executive

Luke Shaw - chief financial officer

Peel Hunt LLP (Nomad and joint broker)

Telephone: 020 7418 8900

Dan Webster

Andrew Clark

Lalit Bose

finnCap (Joint broker)

Telephone: 020 7220 0500

Tim Redfern

Harriet Ward

Hudson Sandler (Financial PR)

Telephone: 020 7796 4133

Charlie Jack

Francis Kerrigan

Amelia Craddock

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOABSGDXSXBDGXX
Date   Source Headline
20th Feb 20237:00 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSTransaction in Own Shares
16th Feb 20237:00 amRNSNew mill
15th Feb 20237:00 amRNSTransaction in Own Shares
14th Feb 20237:00 amRNSTransaction in Own Shares
13th Feb 20237:00 amRNSTransaction in Own Shares
9th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20237:00 amRNSTransaction in Own Shares
3rd Feb 20237:00 amRNSTransaction in Own Shares
2nd Feb 20237:00 amRNSTransaction in Own Shares
1st Feb 20233:48 pmRNSTotal Voting Rights
1st Feb 20237:00 amRNSTransaction in Own Shares
31st Jan 20237:00 amRNSTransaction in Own Shares
30th Jan 20237:00 amRNSAppointment of director
30th Jan 20237:00 amRNSTransaction in Own Shares
27th Jan 20237:00 amRNSTransaction in Own Shares
26th Jan 20237:00 amRNSTransaction in Own Shares
24th Jan 20237:00 amRNSTransaction in Own Shares
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares
17th Jan 20239:10 amRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20232:01 pmRNSDirector/PDMR Shareholding
16th Jan 20237:00 amRNSTransaction in Own Shares
16th Jan 20237:00 amRNSCrop and production
13th Jan 20237:00 amRNSTransaction in Own Shares
12th Jan 20237:00 amRNSTransaction in Own Shares
10th Jan 20237:00 amRNSTransaction in Own Shares
9th Jan 20237:00 amRNSTransaction in Own Shares
6th Jan 20234:53 pmRNSDirector/PDMR Shareholding
6th Jan 20237:00 amRNSTransaction in Own Shares
5th Jan 20237:00 amRNSTransaction in Own Shares
4th Jan 20237:00 amRNSTransaction in Own Shares
3rd Jan 20233:52 pmRNSBlock listing Interim Review
3rd Jan 202312:08 pmRNSTotal Voting Rights
3rd Jan 20237:00 amRNSTransaction in Own Shares
30th Dec 20227:00 amRNSTransaction in Own Shares
29th Dec 20227:00 amRNSTransaction in Own Shares
28th Dec 20227:00 amRNSTransaction in Own Shares
22nd Dec 20221:07 pmRNSTransaction in Own Shares
22nd Dec 20227:00 amRNSTransaction in Own Shares
21st Dec 20227:00 amRNSTransaction in Own Shares
19th Dec 20227:00 amRNSShare buyback extension
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSTransaction in Own Shares
9th Dec 20227:00 amRNSTransaction in Own Shares
8th Dec 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.